Cannabis in Ukraine gains ground in oncology care
Cannabis in Ukraine reaches cancer patients. Learn how legislation has changed and what the rules are for accessing these medications.
Cannabis in Ukraine - Amid the challenges of facing cancer, finding ways to relieve pain and preserve quality of life can make a real difference in the treatment journey. In southern Ukraine, oncology patients have begun receiving medical cannabis-based treatments at a pharmacy in Mykolaiv, an advance that brings regulation closer to the reality of those in need of care. This milestone also highlights how the country has been structuring access to these therapies.
In this article, you will learn:
- How access to cannabis works in Ukraine
- What changed in Ukrainian legislation
- How these medications can help cancer patients
- What challenges remain to expanding access
Cannabis in Ukraine: cancer patients receive medications
According to a report published on October 15, 2026, by the Spanish outlet Cañamo, a pharmacy in Mykolaiv, southern Ukraine, began compounding cannabis-based medications for cancer patients.
The information was released by the Mykolaiv Regional Council and public broadcaster Suspilne. According to the report, since early October, two oncology patients had received prescriptions for these compounded preparations, including a patient treated at the Regional Oncology Center.
The medications are prepared on demand, following the specific composition and dosage indicated in the electronic prescription. Before compounding, the pharmacy team verifies the prescription and consults the prescribing physician if any questions arise.
The initiative also relies on training healthcare professionals and fostering integration between doctors and pharmacists—crucial steps to ensuring the responsible use of these products.
How does medical cannabis work in Ukraine?
The arrival of these medications in Mykolaiv is part of a regulatory shift that took years to materialize.
In December 2023, Ukraine passed Law No. 3528-IX, which laid the groundwork for regulating the circulation of cannabis for medical, scientific, and industrial purposes. The legislation took effect in August 2024, enabling the implementation of specific sector rules.
The new framework provides for oversight of production, storage, transportation, and dispensing of products. Medical access is granted through electronic prescriptions and authorized establishments, supported by traceability mechanisms to monitor the medications.
This change does not represent the legalization of recreational use. Ukrainian regulations maintain restrictions and establish strict conditions for the medicinal use of the plant and its derivatives.
In September 2024, the Ukrainian Ministry of Health also published a list of diseases and conditions for which cannabis-based medicines may be prescribed, along with clinical guidelines for their use.
READ MORE: Amid the war, a Ukrainian company expands hemp production and looks to international markets
Medical cannabis for cancer patients: what is the goal?
The medicinal use of cannabis has been studied across various clinical settings, particularly in managing symptoms that can undermine well-being during complex treatments.
In Ukraine, authorized indications include specific chronic pain conditions, neuropathic pain, and spasticity, as well as chemotherapy-induced nausea and vomiting, in line with Ministry of Health guidelines.
These medications should not be confused with a cure for cancer. The goal is to provide a therapeutic option for specific symptoms, guided by medical evaluation and national health regulations.
The choice of treatment depends on the patient's clinical profile, concurrent medications, and individual response. The dosage and therapeutic regimen must be determined by the attending professional, taking into account potential side effects and drug interactions.
Consequently, the use of medical cannabis during oncological treatment requires professional supervision and should never replace prescribed anticancer therapies.
Access to cannabis in Ukraine expands beyond major hubs
The experience in Mykolaiv carries forward a phase that began in other Ukrainian cities.
On June 11, 2026, patients received cannabis-based medications for the first time in the country through electronic prescriptions. According to the State Expert Center of the Ministry of Health of Ukraine, the first recipients included war veterans and individuals living with multiple sclerosis and cancer.
The agency stressed that deploying the system requires more than simply authorizing products: it is essential to establish oversight mechanisms, train professionals, and broaden conditions for access.
This context helps underscore the significance of the southern initiative. Regulation only turns into tangible care when medications reach pharmacies and can be safely prescribed and dispensed under established rules.
READ MORE: Medical cannabis will arrive in Ukraine in 2025, says Minister of Justice
What lies ahead for cannabis in Ukraine?
The case of Mykolaiv shows how cannabis policy in Ukraine is transitioning from legislation to clinical practice. At the same time, expanding access depends on medication availability, professional education, and the capacity to meet patient needs safely.
For those facing cancer, symptom management can represent a vital part of comprehensive care. When indicated, medical cannabis enters this space as a targeted therapeutic option, subject to medical evaluation and available evidence.
While Ukraine's rollout is still evolving, it highlights a central truth: regulation is merely the first step. Ensuring that patients have safe, monitored, and adequate access tailored to their needs remains the ongoing challenge.